Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Lymphocytic, Chronic, B-Cell × 3-aminopyridine-2-carboxaldehyde thiosemicarbazone × 1 year × Clear all

Sponsor

Conditions

Uterine Cervical Neoplasms 2 Neuroendocrine Tumors 2 Glioblastoma 2 Vaginal Neoplasms 1 Lymphoma, Follicular 1 Endometrial Serous Adenocarcinoma 1 Astrocytoma 1

Interventions

venetoclax 61 Cyclophosphamide 51 ibrutinib 46 obinutuzumab 42 acalabrutinib 41 Rituximab 40 fludarabine 32 fludarabine phosphate 27 Specimen Handling 25 zanubrutinib 24 pirtobrutinib 23 Biopsy 22 Whole-Body Irradiation 16 Bendamustine Hydrochloride 16 Mycophenolic Acid 13 Magnetic Resonance Spectroscopy 13 Lenalidomide 12 Tacrolimus 8 Sirolimus 7 Peripheral Blood Stem Cell Transplantation 7 idelalisib 6 Prednisone 6 Melphalan 6 CT-P10 6 Busulfan 6 tafasitamab 5 pembrolizumab 5 ofatumumab 5 Stem Cell Transplantation 5 Etoposide 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡